The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Claudin 18.2 determination in locally advanced gastric and gastroesophageal adenocarcinoma treated with neoadjuvant chemotherapy.
 
Lorenzo Gervaso
No Relationships to Disclose
 
Chiara Cella
No Relationships to Disclose
 
Renato Lobrano
No Relationships to Disclose
 
Stefano De Pascale
No Relationships to Disclose
 
Lavinia Benini
No Relationships to Disclose
 
Francesca Spada
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis
Speakers' Bureau - Advanced Accelerator Applications; Ipsen; Novartis
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen; Novartis
 
Giuseppe De Roberto
No Relationships to Disclose
 
Uberto Fumagalli Romario
Employment - Società Ossigeno Liquido - Vivisol (I)
Leadership - Società Ossigeno Liquido - Vivisol (I)
Stock and Other Ownership Interests - Società Ossigeno Liquido - Vivisol
 
Elena Guerini Rocco
Honoraria - AstraZeneca; Novartis; Roche; Thermo Fisher Scientific
Consulting or Advisory Role - Exact Sciences; Novartis
Research Funding - Thermo Fisher Scientific (Inst)
 
Nicola Fazio
Honoraria - Advanced Accelerator Applications; Merck; Novartis
Consulting or Advisory Role - Advanced Accelerator Applications; Hutchison MediPharma; Merck Serono
Research Funding - Advanced Accelerator Applications; Ipsen (Inst); Merck Serono (Inst)